Source:http://linkedlifedata.com/resource/pubmed/id/16220541
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-14
|
pubmed:abstractText |
Immunological adjuvants increase the clonal burst size of antigen-specific T cell populations by mechanisms that remain incompletely understood. Using the DO11.10 adoptive transfer system to study peptide-stimulated T cell responses, we found that TLR agonist treatment increased the extent of cellular division undergone by responding T cells, but not by enough to explain the net increases in T cell yield that were achieved. Two novel analyses involving CFSE dye dilution analysis were used to characterize the shortfall, both of which were consistent with the idea that DO11.10 T cells are frequently lost during proliferation unless TLR agonists are present. T cell loss during clonal expansion was correlated with decreased levels of Bcl-2, but TLR agonists did not appear to afford protection by restoring levels of Bcl-2 or of cell surface IL-7Ralpha chain expression. TLR-mediated protection also failed to correlate with increased expression of Bcl-x or decreased expression of pro-apoptotic Bim. Our findings suggest that DO11.10 T cells stimulated by antigenic peptide in vivo divide well, but fail to accumulate efficiently unless TLR agonists are present.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-7,
http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptors,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-7 receptor, alpha chain
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3196-208
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16220541-Animals,
pubmed-meshheading:16220541-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16220541-Cell Aggregation,
pubmed-meshheading:16220541-Cell Cycle,
pubmed-meshheading:16220541-Cell Division,
pubmed-meshheading:16220541-Cell Lineage,
pubmed-meshheading:16220541-Clone Cells,
pubmed-meshheading:16220541-Lymphoid Tissue,
pubmed-meshheading:16220541-Mice,
pubmed-meshheading:16220541-Mice, Congenic,
pubmed-meshheading:16220541-Mice, Inbred C57BL,
pubmed-meshheading:16220541-Mice, Transgenic,
pubmed-meshheading:16220541-Peptides,
pubmed-meshheading:16220541-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:16220541-Receptors, Interleukin-7,
pubmed-meshheading:16220541-T-Lymphocyte Subsets,
pubmed-meshheading:16220541-Toll-Like Receptors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Peptide-stimulated DO11.10 T cells divide well but accumulate poorly in the absence of TLR agonist treatment.
|
pubmed:affiliation |
Institute for Cellular Therapeutics, Department of Microbiology and Immunology, University of Louisville Medical School, Louisville, KY, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|